India should eliminate tax on drugs for cancer treatment and for chronic and rare diseases, the chairperson of major ...

Biocon share price gained 2.61 per cent at Rs 398 a piece on the BSE in Thursday’s intraday trade. This came after the ...

Syngene reported 18% YoY growth in Q3FY25 net profit. Revenue rose 11% YoY. EBITDA margin improved to 31.4%. Company expects ...

Biocon advanced 2.41% to Rs 397.20 after its board is scheduled to meet on Monday, 27 January 2025, to consider and approve the raising of funds on a private placement basis.

Biocon stock price is poised for a fresh breakout from its consolidation range of 320-395, following nearly three and a half ...

To make cancer care more affordable in price-sensitive India, Mazumdar-Shaw said, the government must also cut import duties ...

Bajaj Finserv Ltd. has garnered multiple buy recommendations from various analysts, all predicting an upward movement in the ...

The Ministry of External Affairs announced on Thursday that it will host the inaugural edition of the ‘Technology Dialogue’ ...

CCI fines Goldman Sachs for undisclosed investment in Biocon, highlighting need for compliance with competition laws in ...

The market may extend its upward journey, but sustainability is the key to watch, given the elevated volatility. Below are ...

The Competition Commission of India fined Goldman Sachs AIMPL Rs 40 lakh for not notifying it about a deal that included ...